Evidence database

Best practice portal main page

Pharmacological treatment (OST) vs placebo treatment to reduce use in female drug-using offenders

Summary of the evidence

Rating
  • Unknown effectiveness

Pharmacological treatment (Buprenorphine) for female drug-using offenders was found in a systematic review (Perry et al., 2015) to have no different effect than placebo in:

  • reducing drug use - self-reported at three months follow-up (RR 0.58, 95 % CI 0.25 to 1.35, 1 study, N=36)

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option
  • Pharmacological treatment
Desired outcome(s)
  • reduce substance use
Area(s)
  • Treatment
Specific substance or pattern of use
  • opioids
Target group(s) or setting(s)
  • women
  • prison

References

Explore all resources in the Best practice portal

 

Miniguides

A one-stop-shop for anyone planning or delivering health and social responses.

 

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

 

Evidence

All of the latest research and evidence on drug-related interventions.

 

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

About the Best practice portal

Collaborations and partnerships in best practice

Logo of the Cochrane Collaboration
Logo of the Campbell Collaboration
Grade logo
WHO logo
Top